BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23001021)

  • 1. Neurofibromatosis type 1 (NF1) associated with tumor of the corpus callosum.
    Pascual-Castroviejo I; Pascual-Pascual SI
    Childs Nerv Syst; 2012 Dec; 28(12):2177-80. PubMed ID: 23001021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Corpus callosum tumor as the presenting symptom of neurofibromatosis type 1 in a patient and literature review].
    Pascual-Castroviejo I; Pascual-Pascual SI; Velazquez-Fragua R; Viaño J
    Rev Neurol; 2012 Nov; 55(9):528-32. PubMed ID: 23111991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corpus callosum morphology and its relationship to cognitive function in neurofibromatosis type 1.
    Pride N; Payne JM; Webster R; Shores EA; Rae C; North KN
    J Child Neurol; 2010 Jul; 25(7):834-41. PubMed ID: 20142468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological profile in adults with neurofibromatosis type 1 compared to a control group.
    Descheemaeker MJ; Plasschaert E; Frijns JP; Legius E
    J Intellect Disabil Res; 2013 Sep; 57(9):874-86. PubMed ID: 23095048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-related gene expression profiles in NF1-associated pilocytic astrocytomas.
    Li J; Perry A; James CD; Gutmann DH
    Neurology; 2001 Apr; 56(7):885-90. PubMed ID: 11294925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying Lesions of the Corpus Callosum in Patients With Neurofibromatosis Type 1.
    Jandhyala NR; Garcia MR; Kim M; Yohay K; Segal D
    Pediatr Neurol; 2024 Jul; 156():66-71. PubMed ID: 38733856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The adverse influence of attention-deficit disorder with or without hyperactivity on cognition in neurofibromatosis type 1.
    Lidzba K; Granström S; Lindenau J; Mautner VF
    Dev Med Child Neurol; 2012 Oct; 54(10):892-7. PubMed ID: 22881119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are morphological and structural MRI characteristics related to specific cognitive impairments in neurofibromatosis type 1 (NF1) children?
    Baudou E; Nemmi F; Biotteau M; Maziero S; Assaiante C; Cignetti F; Vaugoyeau M; Audic F; Peran P; Chaix Y
    Eur J Paediatr Neurol; 2020 Sep; 28():89-100. PubMed ID: 32893091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative morphology of the corpus callosum in children with neurofibromatosis and attention-deficit hyperactivity disorder.
    Kayl AE; Moore BD; Slopis JM; Jackson EF; Leeds NE
    J Child Neurol; 2000 Feb; 15(2):90-6. PubMed ID: 10695893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple pilocytic astrocytomas of the cerebellum in a 17-year-old patient with neurofibromatosis type I.
    Dunn IF; Agarwalla PK; Papanastassiou AM; Butler WE; Smith ER
    Childs Nerv Syst; 2007 Oct; 23(10):1191-4. PubMed ID: 17457593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White matter is increased in the brains of adults with neurofibromatosis 1.
    Wang S; Friedman JM; Suppa P; Buchert R; Mautner VF
    Orphanet J Rare Dis; 2022 Mar; 17(1):115. PubMed ID: 35248131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lesions of the corpus callosum in children with neurofibromatosis 1.
    Mimouni-Bloch A; Kornreich L; Kaadan W; Steinberg T; Shuper A
    Pediatr Neurol; 2008 Jun; 38(6):406-10. PubMed ID: 18486822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is executive function specifically impaired in children with neurofibromatosis type 1? A neuropsychological investigation of cognitive flexibility.
    Roy A; Barbarot S; Roulin JL; Charbonnier V; Fasotti L; Stalder JF; Le Gall D
    Appl Neuropsychol Child; 2014; 3(2):94-102. PubMed ID: 24716868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neurofibromatosis type I (NF1): peculiarities and complications].
    Pascual-Castroviejo I
    Rev Neurol; 1996 Sep; 24(133):1051-5. PubMed ID: 8755343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tumour of the corpus callosum: the association between interhemispheric disconnection and an anterograde amnesia syndrome].
    Bustamante J; Lopera F
    Rev Neurol; 2006 Aug 16-31; 43(4):207-12. PubMed ID: 16883509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain morphometry, T2-weighted hyperintensities, and IQ in children with neurofibromatosis type 1.
    Greenwood RS; Tupler LA; Whitt JK; Buu A; Dombeck CB; Harp AG; Payne ME; Eastwood JD; Krishnan KR; MacFall JR
    Arch Neurol; 2005 Dec; 62(12):1904-8. PubMed ID: 16344348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary observations on genetic alterations in pilocytic astrocytomas associated with neurofibromatosis 1.
    Tada K; Kochi M; Saya H; Kuratsu J; Shiraishi S; Kamiryo T; Shinojima N; Ushio Y
    Neuro Oncol; 2003 Oct; 5(4):228-34. PubMed ID: 14565158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of ADHD in neurofibromatosis type 1.
    Mautner VF; Kluwe L; Thakker SD; Leark RA
    Dev Med Child Neurol; 2002 Mar; 44(3):164-70. PubMed ID: 12005317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurofibromatosis type 1 and high-grade tumors of the central nervous system.
    Rosenfeld A; Listernick R; Charrow J; Goldman S
    Childs Nerv Syst; 2010 May; 26(5):663-7. PubMed ID: 19937438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive dysfunction in children with neurofibromatosis type 1.
    Rosser TL; Packer RJ
    Curr Neurol Neurosci Rep; 2003 Mar; 3(2):129-36. PubMed ID: 12583841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.